Rachel Lane, Ph.D.
Interim Chief Business Officer
Dr. Lane is an investor at Versant Ventures and business development executive with over 10 years’ experience leading R&D collaborations and portfolio strategy across the biotech industry. Prior to joining Versant, Rachel was Director, Business Development at Calico Life Sciences where she established several external partnerships and led the company into a new therapeutic area. Prior to Calico, she was Sr. Director of Business Development at Ovid Therapeutics. Rachel started her career in non-profit at the Alzheimer’s Drug Discovery Foundation leading early-stage investments before joining Wall Street as a Research Analyst.